Where does CollPlant Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CollPlant Ltd. ranks #20,946 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CollPlant Ltd. hold?

CollPlant Ltd. holds 13 US utility patents granted between 2015 and 2025, spanning 19 technology areas.

What is CollPlant Ltd.'s Innovation Score?

CollPlant Ltd. has an Innovation Score of 35.7 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CollPlant Ltd. focus on?

CollPlant Ltd.'s top technology area is C07K (Peptides) with 10 patents, ranking #887 of 3,615 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

Is CollPlant Ltd.'s patent grant rate increasing or decreasing?

CollPlant Ltd.'s recent grant velocity is -29% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for CollPlant Ltd.'s patents?

CollPlant Ltd.'s patents average 13.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CollPlant Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CollPlant Ltd.

USPTO PatentsView assignee record - 13 granted patents across 19 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Collplant ranks #20,946 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 19 technology areas.

#20,946
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.7/100): 13.0
avg claims per patent: -29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20946 · Foreign Corporation #20,946 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,946/49,997
PHOTO-FINISH Clarity Medical…
CPC-FOCUS C07K · 19 areas
INNOV-THIN 35.7/100
CLAIMS-RICH 13.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clarity Medical Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Collplant’s 35.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (26%) Velocity 3.3 pts (9%) Breadth 15.4 pts (43%) Claim depth 7.8 pts (22%)

Qualcomm Incorporated · highest

85
CollPlant · this assignee

36
3D Lighting… · lowest

7

What this shows Collplant's Innovation Score is 35.7/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Collplant?

Each dot is one of Collplant’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Collplant’s own 13.0 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Collplant vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Collplant's grants concentrate

CollPlant Ltd. is a focused PatentsView assignee: 19 CPC subclasses with 76.9% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Collplant sits between Clarity Medical Systems, Inc. and Compart Systems Pte. Ltd..

Collplant's three-year grant acceleration

CollPlant Ltd. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Clarity Medical S…

13
Cleland Sales

13
Cleveland Reclaim…

13
Cogito

13
Collectivehealth

13
Collegium Pharmac…

13
Colossio

13
Compart Systems P…

13
Collplant ◀

13

What this shows CollPlant holds 13 patents at rank #20,957, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CollPlant

By rank, the assignees closest to #20,957 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in CollPlant's primary technology class.

Collplant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

CollPlant Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	15.4%
2016	1	7.7%
2017	3	23.1%
2019	1	7.7%
2020	3	23.1%
2023	1	7.7%
2024	1	7.7%
2025partial year	1	7.7%

Which technologies does CollPlant Ltd. patent most?

C07K - Peptides 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

C08B - POLYSACCHARIDES; Derivatives Thereof 6

C08L - Compositions OF Macromolecular Compounds 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

C08H - Derivatives OF Natural Macromolecular Compounds 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

C12Y - Enzymes 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 1

D01F - Chemical Features IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR RIBBONS; Apparatus Specially Adapted FOR THE Manufacture OF Carbon Filaments 1

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CollPlant Ltd.'s patent record in context - here's where to go next.

CollPlant Ltd.'s lead technology class is C07K (Peptides), 76.9% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #20,946 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CollPlant Ltd. against Clarity Medical Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.